ROSENBLUM, PHD, A.; CRUCIANI, MD, PHD, R. A.; STRAIN, MD, E. C.; CLELAND, PHD, C. M.; JOSEPH, PHD, H.; MAGURA, PHD, CSW, S.; MARSCH, PHD, L. A.; MCNICHOLAS, MD, PHD, L. F.; SAVAGE, MD, MS, S. R.; SUNDARAM, BA, A.; PORTENOY, MD, R. K. Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: Development and pilot test of a clinical protocol. Journal of Opioid Management, [S. l.], v. 8, n. 6, p. 369–382, 2012. DOI: 10.5055/jom.2012.0137a. Disponível em: https://wmpllc.org/ojs/index.php/jom/article/view/22. Acesso em: 27 apr. 2024.